Mah Sing gets approval to market gloves in US

“With the updated 510(k) clearance, Mah Sing Healthcare will be able to market medical-grade examination gloves which can be used in the handling or preparation of chemotherapeutic drugs in the US. “This will enable big medical players in the US to obtain gloves from Mah Sing Healthcare as their existing suppliers also carry the chemotherapy protection claim,” the group said in a statement yesterday.

PETALING JAYA: Mah Sing Group Bhd’s indirectly owned unit, Mah Sing Healthcare Sdn Bhd, has received the 510(k) premarket notification clearance to market its nitrile examination gloves and tested for use with chemotherapy drugs from the United States Food and Drug Administration (FDA).

“With the updated 510(k) clearance, Mah Sing Healthcare will be able to market medical-grade examination gloves which can be used in the handling or preparation of chemotherapeutic drugs in the US.